References
Butler VP, Chen JP. Digoxin specific antibodies. Proceedings of the National Academy of Sciences (USA) 57: 71–78, 1967
Cole PL, Smith TW. Use of digoxin-specific Fab fragments in the treatment of digitalis intoxication. Drug Intelligence and Clinical Pharmacy 20: 267–269, 1986
Hoffman BF, Bigger Jr JT. Cardovascular drugs. In Goodman and Gilman’s the Pharmacologic basis of therapeutics pp. 716-747, 7th ed., MacMillan Publishing Co. Inc., 1980
Lloyd BL, Smith TW. Contrasting rates of reversal of digoxin toxicity by digoxin-specific IgG and Fab fragments. Circulation 58: 280–283, 1978
Smith, TW. Advances in the assessment and treatment of digitalis toxicity. Journal of Clinical Pharmacology 25: 522–528, 1985
Smith TW, Butler VP, Haber E, Foggard H, Marcus FI, et al. Treatment of life threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. New England Journal of Medicine 307: 1357–1362, 1982
Smith TW, Haber E, Yeatman L, Butler VP. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibiotics, Journal of the American College Cardiology 5: 118A–123A, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stolshek, B.S., Osterhout, S.K. & Dunham, G. The Role of Digoxin-Specific Antibodies in the Treatment of Digitalis Poisoning. Medical Toxicology 3, 167–171 (1988). https://doi.org/10.1007/BF03259880
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03259880